Late-gestation betamethasone enhances coronary artery responsiveness to angiotensin II in fetal sheep

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Roghair, Robert D ^a   Lamb, Fred S ^a   Bedell, Kurt A ^a   Smith, Oliva M ^a   Scholz, Thomas D ^a   Segar, Jeffrey L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

Author keywords

Coronary artery; Vascular smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 8 BROMO CYCLIC GMP; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BETAMETHASONE; FORSKOLIN; GLUCOCORTICOID; ISOPRENALINE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; FETUS; FETUS MATURITY; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; WESTERN BLOTTING;

EID: 0346096880     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00421.2003     Document Type: Article

References (46)

1. American College of Obstetricians and Gynecologists. Committee on Obstetric Practice Antenatal corticosteroid therapy for fetal maturation. Int J Gynaecol Obstet 64: 334-335, 1999.
2. Anwar MA, Schwab M, Poston L, and Nathanielsz PW. Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus. Am J Physiol Heart Circ Physiol 276: H1137-H1143, 1999.
3. Banks BA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181: 709-717, 1999.
4. Burrell JH, Hegarty BD, McMullen JR, and Lumbers ER. Effects of gestation on ovine fetal and maternal angiotensin receptor subtypes in the heart and major blood vessels. Exp Physiol 86: 71-82, 2001.
5. Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, and Johnson AL. Identification of angiotensin 11 receptor subtypes. Biochem Biophys Res Commun 165: 196-203, 1989.
6. Cox BE and Rosenfeld CR. Ontogeny of vascular angiotensin 11 receptor subtype expression in ovine development. Pediatr Res 45: 414-424, 1999.
7. Crowley P. Prophylactic corticosteroids for preterm birth (Cochrane review). Cochrane Library, Issue 4. Chichester, UK: John Wiley and Sons, 2003.
8. Davidson D. Circulating vasoactive substances and hemodynamic adjustments at birth in lambs. J Appl Physiol 63:676-684, 1987.
9. Docherty CC, Kalmar-Nagy J, Engelen M, Koenen SV, Nijland M, Kuc RE, Davenport AP, and Nathanielsz PW. Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol 281: R261-R268, 2001.
10. Dodic M and Wintour EM. Effects of prolonged (48 h) infusion of cortisol on blood pressure, renal function and fetal fluids in the immature ovine foetus. Clin Exp Pharmacol Physiol 21: 971-980, 1994.
11. Doyle LW, Ford GW, Davis NM, and Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci 98: 137-142, 2000.
12. French NP, Hagan R, Evans S, Godfrey M, and Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180: 114-121, 1998.
13. Gao Y, Zhou H, and Raj JU. Antenatal betamethasone therapy potentiates nitric oxide-mediated relaxation of preterm ovine coronary arteries. Am J Physiol Heart Circ Physiol 270: H538-H544, 1996.
14. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin 11 signaling. Regul Pept 91: 21-27, 2000.
15. Horiuchi M, Akishita M, and Dzau VJ. Recent progress in anigotensin II type 2 receptor research in the cardiovascular system. Hypertension 33: 613-621, 1999.
16. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, and Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 156: 178-184, 1997.
17. Levitt N, Lindsay RS, Holmes MC, and Seckl JR. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64: 412-418, 1996.
18. Liggins GC and Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50: 515-525, 1972.
19. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, and Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin ATI receptor. Nature 375: 247-250, 1995.
20. Mellor DJ. Vascular anastomosis and fusion of foetal membranes in multiple pregnancy in the sheep. Res Vet Sci 10: 361-367, 1969.
21. Molnar J, Howe DC, Nijland MJ, and Nathanielsz PW. Prenatal dexamethasone leads to both endothelial dysfunction and vasodilatory compensation in sheep. J Physiol 571: 61-66, 2003.
22. Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JRG, and Newnham JP. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol 281: R960-R970, 2001.
23. Murasawa S, Matsubara H, Kanasaki M, Kijima K, Maruyama K, Nio Y, Okubo N, Tsukaguchi H, Mori Y, and Inada M. Characterization of glucocorticoid response element of rat angiotensin II type 1A receptor gene. Biochem Biophys Res Commun 209: 833-840, 1995.
24. a. National Institute of Child Health and Human Development. Report of the Consensus Development Conference on the Effects of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Bethesda, Maryland: NICHD, 1994. (NIH Publication No. 95-3784)
25. Nickenig G and Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis. I. Oxidative stress and atherogenesis. Circulation 105: 393-396, 2002.
26. Nickenig G and Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis. II. AT1 receptor regulation. Circulation 105: 530-536, 2002.
27. Norman LJ, Lye SJ, Wlodek ME, and Challis JR. Changes in pituitary responses to synthetic ovine corticotrophin releasing factor in fetal sheep. Can J Physiol Pharmacol 63: 1398-1403, 1985.
28. Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, and Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101: 2174-2181, 1998.
29. Nyirenda MJ and Seckl JR. Intrauterine events and the programming of adulthood disease: the role of fetal glucocorticoid exposure. Int J Mol Med 2: 607-614, 1998.
30. Peers A, Campbell DJ, Wintour EM, and Dodic M. The peripheral renin-angiotensin system is not involved in the hypertension of sheep exposed to prenatal dexamethasone. Clin Exp Pharmacol Physiol 28: 306-311, 2001.
31. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346-356, 1977.
32. Quinlivan JA, Evans SF, Dunlop SA, Beazley LD, and Newnham JP. Use of corticosteroids by Australian obstetricians: a survey of clinical practice. Aust NZ J Obstet Gynaecol 38: 1-7, 1998.
33. 1) receptor gene expression during fetal and newborn life. Pediatr Res 36: 755-762, 1994.
34. Schmidt-Ott KM, Kagiyama S, and Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 93: 65-77, 2000.
35. Segar JL, Barna TJ, Acarregui MJ, and Lamb FS. Responses of fetal ovine systemic and umbilical arteries to angiotensin II. Pediatr Res 49: 826-833, 2001.
36. Segar JL, Bedell KA, Page WV, Mazursky JE, Nuyt AM, and Robillard JE. Effect of cortisol on gene expression of the renin-angiotensin system in fetal sheep. Pediatr Res 37: 741-746, 1995.
37. Segar JL, Bedell KA, and Smith OJ. Glucocorticoid modulation of cardiovascular and autonomic function in preterm lambs: role of ANG II. Am J Physiol Regul Integr Comp Physiol 280: R646-R654, 2001.
38. 1 receptor blockade fails to attenuate pressure-overload cardiac hypertrophy in fetal sheep. Am J Physiol Regul Integr Comp Physiol 273: R1501-R1508, 1997.
39. Servant G, Dudley DT, Escher E, and Guillemette G. The marked disparity between the sizes of angiotensin type 2 receptors from different tissues is related to different degrees of N-glycosylation. Mol Pharmacol 45: 1112-1118, 1994.
40. Shanmugam S and Sandberg K. Ontogeny of angiotensin II receptors. Cell Biol Int 20: 169-176, 1996.
41. Smith RD, Chiu AT, Wong PC, Herblin WF, and Timmermans PB. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 32: 135-165, 1992.
42. Taketomo C, Hodding JH, and Kraus DM. Pediatric Dosage Handbook (6th ed.). Cleveland, OH: Lexi-Comp, 1999-2000.
43. Vermillion ST, Soper DE, and Newman RB. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am J Obstet Gynecol 183: 810-814, 2000.
44. Wallerath T, Witte K, Schäfer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, and Förstermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Aceid Sci USA 96: 13357-13362, 1999.
45. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, and Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 81: 482-490, 1990.
46. Zhang C, Hein TW, Wang W, and Kuo L. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ Res 92: 322-329, 2003.